A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
UCL Awards for Enterprise 2014
Publication date: Jun 27, 2013 03:49 PM
Start: May 29, 2014 06:15 PM
Location: UCL Bloomsbury Theatre
The UCL Awards for Enterprise honour the efforts and accomplishments of UCL’s innovative and entrepreneurial academics and students.
The awards ceremony and reception highlight UCL as a leading hub of innovation and commercial activity, while bringing together academics with businesses and investors.